Wolfgang Glaesner

534 total citations
9 papers, 414 citations indexed

About

Wolfgang Glaesner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wolfgang Glaesner has authored 9 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wolfgang Glaesner's work include Diabetes Treatment and Management (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Wolfgang Glaesner is often cited by papers focused on Diabetes Treatment and Management (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Wolfgang Glaesner collaborates with scholars based in United States and Canada. Wolfgang Glaesner's co-authors include Yu Tian, Anja Köester, Andrew Vick, Niels Pörksen, Rohn Millican, Martin Brenner, Bernice Ellis, Garret J. Etgen, Krister Bokvist and Derrick R. Witcher and has published in prestigious journals such as Biochemistry, Journal of Lipid Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Wolfgang Glaesner

8 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Glaesner United States 7 210 205 96 74 46 9 414
Kuniko Kikuchi Japan 6 276 1.3× 92 0.4× 185 1.9× 31 0.4× 150 3.3× 7 517
Naim Panjwani Canada 7 198 0.9× 226 1.1× 150 1.6× 20 0.3× 19 0.4× 10 443
Lingling Du China 11 122 0.6× 89 0.4× 41 0.4× 72 1.0× 17 0.4× 15 387
Veena A. Thomas United States 8 163 0.8× 146 0.7× 49 0.5× 53 0.7× 82 1.8× 11 358
Laurent Bermont France 11 207 1.0× 78 0.4× 45 0.5× 17 0.2× 42 0.9× 23 398
Toshitsugu Kariya Japan 12 169 0.8× 92 0.4× 59 0.6× 9 0.1× 26 0.6× 26 385
Sindy Rabe Germany 12 197 0.9× 86 0.4× 44 0.5× 17 0.2× 19 0.4× 20 324
Aishwariya Sharma Canada 9 170 0.8× 68 0.3× 42 0.4× 19 0.3× 11 0.2× 16 372
Rebecca A. Sendak United States 9 173 0.8× 201 1.0× 29 0.3× 23 0.3× 8 0.2× 15 395
Bibi S. van Thiel Netherlands 7 113 0.5× 61 0.3× 45 0.5× 19 0.3× 22 0.5× 10 296

Countries citing papers authored by Wolfgang Glaesner

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Glaesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Glaesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Glaesner more than expected).

Fields of papers citing papers by Wolfgang Glaesner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Glaesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Glaesner. The network helps show where Wolfgang Glaesner may publish in the future.

Co-authorship network of co-authors of Wolfgang Glaesner

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Glaesner. A scholar is included among the top collaborators of Wolfgang Glaesner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Glaesner. Wolfgang Glaesner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Balasubramaniam, Deepa, Oliver C. Schroeder, Jonathan R. Fitchett, et al.. (2022). An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. Journal of Lipid Research. 63(5). 100198–100198. 32 indexed citations
2.
Pechtner, V., et al.. (2017). A New Approach to Drug Therapy: Fc-Fusion Technology. 7(1). 16 indexed citations
3.
Miličević, Zvonko, Greg Anglin, Kristine D. Harper, et al.. (2016). Low Incidence of Anti-Drug Antibodies in Type 2 Diabetes Patients Treated with Once Weekly GLP-1 Receptor Agonist Dulaglutide: Incidence of anti-drug antibodies with dulaglutide. 1 indexed citations
4.
Miličević, Zvonko, Greg Anglin, Kristine D. Harper, et al.. (2016). Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide. Diabetes Obesity and Metabolism. 18(5). 533–536. 22 indexed citations
5.
Mallbris, Lotus, Julian Davies, Andrew L. Glasebrook, et al.. (2016). Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?. PubMed. 9(7). 13–5. 10 indexed citations
6.
Tamaki, Chihiro, Masakazu Takeuchi, Noriyuki Iwamoto, & Wolfgang Glaesner. (2015). Pharmacological profile and clinical trial results of a long-acting, once weekly human GLP-1 receptor agonist Dulaglutide (Genetical Recombination). Folia Pharmacologica Japonica. 146(4). 215–224. 1 indexed citations
7.
Glaesner, Wolfgang, Andrew Vick, Rohn Millican, et al.. (2010). Engineering and characterization of the long‐acting glucagon‐like peptide‐1 analogue LY2189265, an Fc fusion protein. Diabetes/Metabolism Research and Reviews. 26(4). 287–296. 231 indexed citations
8.
Saha, J. K., Jinqi Xia, Steven K. Engle, et al.. (2006). A Model of Controlled Acute Hyperglycemia in Rats: Effects of Insulin and Glucagon-Like Peptide-1 Analog. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1159–1164. 12 indexed citations
9.
Darling, Ryan J., et al.. (2002). Glycosylation of Erythropoietin Affects Receptor Binding Kinetics:  Role of Electrostatic Interactions. Biochemistry. 41(49). 14524–14531. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuniko Kikuchi Breakdown of academic impact, for papers by Naim Panjwani Breakdown of academic impact, for papers by Lingling Du Breakdown of academic impact, for papers by Veena A. Thomas Breakdown of academic impact, for papers by Laurent Bermont Breakdown of academic impact, for papers by Toshitsugu Kariya Breakdown of academic impact, for papers by Sindy Rabe Breakdown of academic impact, for papers by Aishwariya Sharma Breakdown of academic impact, for papers by Rebecca A. Sendak Breakdown of academic impact, for papers by Bibi S. van Thiel
Rankless by CCL
2026